Amee Manges is a molecular epidemiologist and professor at the UBC School of Population & Public Health. She is a scientist at BCCDC and an associate member in the UBC Department of Microbiology and Immunology.
Dr. Manges conducts research in molecular epidemiology, with particular focus on the role of the human intestinal microbiome in health. Her research group is currently investigating whether:
- an agnostic, next generation metagenomic sequencing assay can be used to detect and characterize respiratory RNA viruses;
- a sinonasal microbiota transfer (SNMT) can treat chronic sinusitis patients;
- using microbiota transfer/transplant therapies can help to eradicate highly drug-resistant bacteria ('superbugs') from the body;
- the intestinal microbiome contributes to infant undernutrition; and whether
- cotrimoxazole treatment for HIV exposure/infection or malnutrition in children leads to long-term changes in the intestinal microbiome.
Dr. Manges earned her PhD in epidemiology from the University of California, Berkeley. She has supervised a molecular epidemiology laboratory since 2004 at both McGill University and the University of British Columbia. She integrates next-generation sequencing technologies into genomic and metagenomic epidemiology, specifically in the areas of infectious disease epidemiology and human microbiome research.
For a list of Dr. Manges' publications, see NCBI.
